BDBM479526 3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(imidazo[1,2-a]pyridin-6-yl)- 5-(2H-1,2,3-triazol-2-yl)pyrazine-2- carboxamide::US10898481, Compound 104::US11571420, Compound 104

SMILES Nc1nc(c(nc1C(=O)NCc1ncccc1F)-c1ccc2nccn2c1)-n1nccn1

InChI Key InChIKey=RDQGDQIQBDJGKQ-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 479526   

TargetAdenosine receptor A2a(Human)
TBA

US Patent
LigandPNGBDBM479526(3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(imida...)
Affinity DataIC50: 6.20nMAssay Description:The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
TBA

US Patent
LigandPNGBDBM479526(3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(imida...)
Affinity DataIC50: 6.20nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
TBA

US Patent
LigandPNGBDBM479526(3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(imida...)
Affinity DataIC50: 49nMAssay Description:The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
TBA

US Patent
LigandPNGBDBM479526(3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(imida...)
Affinity DataIC50: 49nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent